Complete response upon salvage chemotherapy after anti-PD1 failure: Watch and wait

Citations Over Time

Related Papers

• → Tumor Mutational Burden and Efficacy of Nivolumab Monotherapy and in Combination with Ipilimumab in Small-Cell Lung Cancer(2018)886 cited
• → Severe infusion reaction due to nivolumab: A case report(2020)8 cited
• → A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell Carcinoma(2023)3 cited
• BIOLUMA: Biomarkers for nivolumab and evaluation of nivolumab plus ipilimumab in lung cancer(2018)
• → P2.04-39 Clinical Characteristics of Long-Term Survivors with Nivolumab in Previously Treated Advanced NSCLC from Real World Data(2019)